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Papillary ependymoma is a rare tumor that may be located along the ventricular walls or within the spinal cord. We report the case
of a 54-year-old patient with a papillary ependymoma WHO grade II arising at the entrance of the aqueduct. The tumor caused
hydrocephalus. The tumor was completely removed via a right-sided endoscopic approach with restoration of the aqueduct. The
free cerebrospinal ﬂuid passage through the aqueduct was not only visualized by endoscopy but also controlled by intraoperative
high-ﬁeld magnetic resonance imaging. Therefore, an additional endoscopic third ventriculostomy was unneccessary.
Copyright © 2009 Andreas M. Stark et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Tumor related obstructive hydrocephalus is a frequent event.
In most cases however, the cerebro spinal ﬂuid (CSF)
pathway is compressed by an intraparenchymal lesion itself
or by the surrounding edema (glioma, brain metastases). In
the minority of cases, tumors arise within the ventricular
walls (choroid plexus papilloma, intraventricular menin-
gioma, ependymoma) [1]. In this condition, endoscopic and
microsurgical techniques can be used either alone or in com-
bination to remove the tumor and restore the cerebro-spinal
ﬂuid (CSF) pathway [2–4]. Surgical intervention might be
followed by chemo- and/or radiotherapy. A speciﬁc subset
of hydrocephalus-inducing tumors is tectal gliomas which
arise around the aqueduct. This tumor type usually requires
only restoration of CSF ﬂow (achieved by endoscopic third
ventriculostomy). Radiotherapy can be applied in cases of
tumor progression [5]. We report a case of hydrocephalus
caused by a small lesion occluding the entrance of the
aqueduct which turned out to be a papillary ependymoma
WHO grade II. The tumor was removed via an endoscopic
approach with restoration of the aqueduct. The operative
result was controlled via intra-operative magnetic resonance
imaging (MRI).
2. Case Presentation
2.1. Clinical Presentation. A 54-year-old man presented to
ourclinicwithprogressiveheadache,visualdisturbance,and,
gait impairment since 9 months. Neurological examination
revealed marked ataxia, no further neurological deﬁcits.
Magnetic resonance imaging (MRI) of the brain revealed
obstructive hydrocephalus (Figure 1) caused by a small
tumor at the cranial entry of the aqueduct (Figure 2(a)).
2.2. Treatment. The patient underwent tumor resection via
a rigid neuroendoscope. Neuronavigation was used as an
aid for exact burrhole placement. We sought to access
the aqueduct as well as, possibly, the ﬂoor of the third
ventricle for third ventriculostomy. The burrhole was placed
right frontal approximately 5cm in front of the coronal
suture. Intraoperatively, the tumor was found to be smooth
and moderately vascularized (Figure 3(a)). The lesion was
coagulated with bipolar coagulation and than removed
using forceps (Figures 3(b) and 3(c)). Intraoperative high-
ﬁeld MRI revealed a free CSF passage of the aqueduct
(Figure 2(b)). As a consequence of this ﬁnding, endoscopic
third ventriculostomy was not performed. A ventricular
drainage was inserted through the burr hole without con-
nection to a drainage system.2 Case Reports in Medicine
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Figure 1: (a) T2-weighted MRI showing marked hydrocephalus, T1-weighted contrast enhanced MRI reveals a small lesion tumor at the
cranial end of the aqueduct in axial (b) and sagittal view (c) and TRUFI sequences (sagittal thin T2-weighted images, (d)).
2.3. Histopathology. Histopathological examination showed
a papillary tumor with increased cellularity. The chro-
matin of the round nuclei was ﬁne granular and the
cytoplasm was eosinopilic. There were small perivascular
anuclear zones with ﬁbrillary processes. Mitoses were absent
(Figure 4(a)). Immunohistochemically the tumor cells were
positive for S-100 Protein (Figure 4(b))b u tn e g a t i v ef o r
GFAP (Figure 4(c)). Elastica-van-Giesson staining showed
reticulin ﬁbers (Figure 4(d)). The Ki67 labelling index (MIB
1-antibody) approached 5%. The tumor was diagnosed as
papillary ependymoma WHO grade II.
2.4. Postoperative Course. Postoperatively, the patient devel-
oped transient headache which was treated by CSF diver-
sion via the ventricular drainage and an additional lum-
bar drainage. Hypothetically, we sought to relief transient
hydrocephalus due to poor resorption in long-standing
hydrocephalus. Herein, the symptoms resolved over few days
and the drains could be removed. He showed also diplopia
which was intermittend at ﬁrst but then remained stable
over the follow-up period of 15 months. Postoperative MRI
revealed no spinal drop metastases.
3. Discussion
Papillary ependymoma is a rare variant of ependymoma.
Thediﬀerentialdiagnosisincludeschoroidplexuspapilloma,
papillary meningioma and metastatic papillary carcinoma
[1]. Ependymomas usually correspond to WHO grade IICase Reports in Medicine 3
GR
TR: 6.4022
TE: 3.2011
SP: 18
SL: 1 C: 289 C: 259
GR
TR: 6.2402
TE: 3.1201
SP: 18
SL: 1
ARH
HLP Q: 95%
Neuroradiologie,
UK-SH, Kiel
Achieva
Q: 95%
Neuroradiologie,
UK-SH, Kiel
Achieva
HLP
ARH PLF PLF
Figure 2: T2-weighted sagittal MRI (left) before and (right) after endoscopic tumor removal with restoration of the aqueduct. The tumor is
marked by arrows.
(a) (b) (c)
Figure 3: Intraoperative endoscopic images of the tumor at the entrance of the aqueduct before (a), within (b), and after tumor resection
(c).
with a ten-year survival rate of approximately 45% in adults.
Anaplastic ependymoma (WHO grade III) is associated with
unfavorable clinical outcome [1]. Other ependymoma vari-
ants are cellular, clear cell and tanycytic types. Furthermore,
ependymomas with lipomatous diﬀerentiation, giant cell
formation, extensive vacuolation, melanotic diﬀerentiation,
signet ring cell appearance and ovarian localization have
been reported. Supratentorial location has a better outcome
than infratentorial location. Spinal location of ependymoma
is also associated with a better prognosis [1, 6].
Reviewing the literature, we found 4 articles fulﬁlling
our request (PubMed, “papillary ependymoma” in the title,
human) which were published between 1963 and 1996. In
1996, Park et al. reported two cases of large papillary ependy-
moma in the left lateral ventricle and the pineal region, both
cases were associated with hydrocephalus [6]. In one case
reported in Italian in 1965, “encephalitic symptomatology
due to a papillary ependymoma of the 3rd ventricle” was
reported [7]. An abstract is not available. Other locations
reported are the cervical spinal cord [8], and the cauda
equine [9]. In the latter case, metastasis to other organs has
been reported.
Inourcase,asmallpapillaryependymomawaslocatedat
the caudal entry of the aqueduct and caused hydrocephalus.
The patient was treated by endoscopic tumor removal
with restoration of the aqueduct. Intraoperative MRI was
used to document macroscopically total tumor resection
and restoration of the aqueduct. In such cases with small
tumors arising along the ventricular walls, macroscopically
total tumor removal should be achieved. In case of failed
or questionable restoration of the aqueduct, endoscopic
third ventriculostomy (ETV) should be performed. Herein,4 Case Reports in Medicine
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Figure 4: Papillary ependymoma: HE (a) S-100 protein (b) GFAP (c), Elastica-van-Giessen staining (d).
intraoperative MRI can be helpful in the decision whether
ETV should be performed or not. Notable, patients should
be followed postoperatively for possible secondary occlusion
of the aqueduct due to adhesions. In this case, ETV might
benecessaryafterwards. Insertionofaventricular-peritoneal
shunt is no longer an alternative as ﬁrst treatment in
these patients [2, 3]. We chose a right frontal burrhole
approximately 5cm before the coronal suture. Herein we
sought to access the aqueduct and, if needed, the ﬂoor of the
third ventricle.
In conclusion, papillary ependymoma is a rare tumor
that arises along the CSF-pathway and may cause hydro-
cephalus. MRI is the key diagnostic tool to deﬁne the
cause of hydrocephalus. Surgery, either open microsurgical
resection or endoscopic resection can erase the tumor. In
small tumors, endoscopy is the treatment of choice. If the
aqueduct can not be restored or restoration is questionable,
endoscopic third ventriculostomy should be performed.
Neuronavigation can be helpful in these case to estimate the
exact angle of endoscopy entrance. Histological examination
of the surgical specimens is the key to diagnosis. Even if the
tumor correnponds to WHO grade II, metastasis to other
organs has been reported.
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